FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

TJ Schroeder

Research Profile

Procedures

Physiology

Chemicals & Drugs

Concepts & Ideas

Disorders

Acute Disease

Living Beings

Tissue Donors

Co-author Network

Publications

TOP 3
Mark A Schnitzler; Robert S Woodward; Jeffrey A Lowell; L Amir; TJ Schroeder; Gary G Singer; Daniel C Brennan
Economics of the antithymocyte globulins Thymoglobulin and Atgam in the treatment of acute renal transplant rejection.
D E Dean; S Kamath; V Ram Peddi; TJ Schroeder; M Roy First; T Cavallo
A blinded retrospective analysis of renal allograft pathology using the Banff schema: implications for clinical management.
MB Shah; Jill E Martin; TJ Schroeder; M Roy First
The evaluation of the safety and tolerability of two formulations of cyclosporine: neoral and sandimmune. A meta-analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of TJ Schroeder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Mark A Schnitzler; Robert S Woodward; Jeffrey A Lowell; L Amir; TJ Schroeder; Gary G Singer; Daniel C Brennan
Economics of the antithymocyte globulins Thymoglobulin and Atgam in the treatment of acute renal transplant rejection.
PharmacoEconomics 2000;17(3):287-93.
1999: D E Dean; S Kamath; V Ram Peddi; TJ Schroeder; M Roy First; T Cavallo
A blinded retrospective analysis of renal allograft pathology using the Banff schema: implications for clinical management.
Transplantation 1999;68(5):642-5.
1999: MB Shah; Jill E Martin; TJ Schroeder; M Roy First
The evaluation of the safety and tolerability of two formulations of cyclosporine: neoral and sandimmune. A meta-analysis.
Transplantation 1999;67(11):1411-7.
1999: J F Regan; K Campbell; L Van Smith; TJ Schroeder; D Womble; JM Kano; Roland Buelow
Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-Center Study Group.
Transplant immunology 1999;7(2):115-21.
1999: Lillian W Gaber; Linda Moore; A Osama Gaber; R J Tesi; J Meyer; TJ Schroeder
Correlation of histology to clinical rejection reversal: a thymoglobulin multicenter trial report.
Kidney international 1999;55(6):2415-22.
1999: Mark A Schnitzler; Robert S Woodward; Jeffrey A Lowell; Gary G Singer; L Amir; HR Horn; JM Kano; TJ Schroeder; Daniel C Brennan
Costs savings associated with thymoglobulin for treatment of acute renal transplant rejection in patient subsets.
Transplantation proceedings 1999;31(3B Suppl):7S-8S.
1999: TJ Schroeder; Linda Moore; Lillian W Gaber; A Osama Gaber; M Roy First
The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design.
Transplantation proceedings 1999;31(3B Suppl):1S-6S.
1999: J E Martin; AJ Daoud; TJ Schroeder; M Roy First
The clinical and economic potential of cyclosporin drug interactions.
PharmacoEconomics 1999;15(4):317-37.
1999: V Ram Peddi; TJ Schroeder; Pat Weiskittel; M Roy First
Graft outcome in patients with biopsy-proven chronic renal allograft rejection.
Transplantation proceedings 1999;31(1-2):1308-9.
1999: Robert A Fisher; Shi-Hui Pan; S J Rossi; TJ Schroeder; WD Irish; DM Canafax; Richard R Lopez
Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients.
Transplantation proceedings 1999;31(1-2):394-5.
1999: Robert S Gaston; R R Alloway; A O Gaber; S J Rossi; TJ Schroeder; WD Irish; DM Canafax; M Roy First
Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients.
Transplantation proceedings 1999;31(1-2):326-7.
1999: M Roy First; Pat Weiskittel; M L Burton; MB Shah; D Dreyer; PR Fleck; C Bey; V Ram Peddi; DM Canafax; TJ Schroeder
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune.
Transplantation proceedings 1999;31(1-2):324-5.
1999: U M Khosla; Jill E Martin; G M Baker; TJ Schroeder; M Roy First
One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation.
Transplantation proceedings 1999;31(1-2):274-5.
1999: MB Shah; Jill E Martin; TJ Schroeder; M Roy First
Validity of open labeled versus blinded trials: a meta-analysis comparing Neoral and Sandimmune.
Transplantation proceedings 1999;31(1-2):217-9.
1998: G M Baker; Jill E Martin; Raymond Jang; TJ Schroeder; J A Armitstead; S Myre; M Roy First
Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
Transplantation proceedings 1998;30(8):4082-4.
1998: AJ Daoud; TJ Schroeder; M Shah; S Hariharan; V Ram Peddi; Pat Weiskittel; M Roy First
A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus.
Transplantation proceedings 1998;30(8):4079-81.
1998: PR Fleck; TJ Schroeder; A J Dauod; V Ram Peddi; M Roy First
Tacrolimus use in kidney-pancreas recipients is associated with less acute renal dysfunction than cyclosporine.
Transplantation proceedings 1998;30(8):4070-2.
1998: MB Shah; Jill E Martin; TJ Schroeder; M Roy First
A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral.
Transplantation proceedings 1998;30(8):4048-53.
1998: M Roy First; Pat Weiskittel; M Shah; V Ram Peddi; DM Canafax; TJ Schroeder
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
Transplantation proceedings 1998;30(8):3955-7.
1998: M Roy First; Rita R Alloway; TJ Schroeder
Development of Sang-35: a cyclosporine formulation bioequivalent to Neoral.
Clinical transplantation 1998;12(6):518-24.
1998: TJ Schroeder; Moo Je Cho; Gary M Pollack; R Floc'h; HB Moran; R Levy; Linda Moore; P Pouletty
Comparison of two cyclosporine formulations in healthy volunteers: bioequivalence of the new Sang-35 formulation and Neoral.
Journal of clinical pharmacology 1998;38(9):807-14.
1998: James Thielke; J Martin; Fredrick L Weber; TJ Schroeder; S Goretsky; Douglas W Hanto
Pharmacokinetics of tacrolimus and cyclosporine in short-bowel syndrome.
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1998;4(5):432-4.
1998: M Roy First; Pat Weiskittel; M Burton; M Shah; D Dreyer; PR Fleck; C Bey; R Peddi; DM Canafax; TJ Schroeder
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method.
Transplantation proceedings 1998;30(5):1701-5.
1998: MB Shah; Jill E Martin; TJ Schroeder; M Roy First
Evaluation of the safety and tolerability of Neoral and Sandimmune: a meta-analysis.
Transplantation proceedings 1998;30(5):1697-700.
1998: A Osama Gaber; M Roy First; R J Tesi; Robert S Gaston; R Mendez; Laura L Mulloy; J A Light; Lillian W Gaber; E Squiers; R J Taylor; J F Neylan; Robert W Steiner; Stuart J Knechtle; Douglas J Norman; Fuad S Shihab; Giacomo P Basadonna; D C Brennan; Ernest Hodge; B D Kahan; L Kahan; S Steinberg; E Steve Woodle; L Chan; John M Ham; TJ Schroeder
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
Transplantation 1998;66(1):29-37.
1998: Jill E Martin; PR Fleck; TJ Schroeder; James F Whiting; Douglas W Hanto
The cost of rejection in liver allograft recipients.
Transplantation proceedings 1998;30(4):1500-1.
1998: S Kamath; D Dean; V Ram Peddi; TJ Schroeder; J Wesley Alexander; T Cavallo; M Roy First
Primary therapy with OKT3 for biopsy-proven acute renal allograft rejection.
Transplantation proceedings 1998;30(4):1178-80.
1998: G Bhat; TJ Schroeder; K Balakrishnan
Can anti-HLA antibody analyses postcardiac transplantation predict acute allograft rejection and survival?
Transplantation proceedings 1998;30(4):1154-7.
1998: A Osama Gaber; Linda Moore; TJ Schroeder
Observations on recovery of renal function following treatment for acute rejection.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(6 Suppl 1):S47-59.
1998: R D Guttmann; Jean-Paul Soulillou; Linda Moore; M Roy First; A Osama Gaber; P Pouletty; TJ Schroeder
Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejection.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(6 Suppl 1):S40-6.
1998: TJ Schroeder; Linda Moore
Efficacy Endpoints Conference on Acute Rejection in Kidney Transplantation: summary report of the database.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(6 Suppl 1):S31-9.
1998: J Wesley Alexander; A Levy; David A Custer; John F Valente; George Babcock; Cora K Ogle; TJ Schroeder
Arginine, fish oil, and donor-specific transfusions independently improve cardiac allograft survival in rats given subtherapeutic doses of cyclosporin.
JPEN. Journal of parenteral and enteral nutrition 1998;22(3):152-5.
1998: V Ram Peddi; S Kamath; TJ Schroeder; Rino Munda; M Roy First
Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection in simultaneous kidney and pancreas transplant recipients.
Transplantation proceedings 1998;30(2):285-7.
1998: Lillian W Gaber; Linda Moore; A Osama Gaber; M Roy First; R D Guttmann; P Pouletty; TJ Schroeder; Jean-Paul Soulillou
Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference.
Transplantation 1998;65(3):376-80.
1997: G Bhat; TJ Schroeder
Clinical role of immunologic monitoring during OKT3 treatment.
Transplantation proceedings 1997;29(8A):21S-26S.
1997: S Kamath; D Dean; V Ram Peddi; TJ Schroeder; J Wesley Alexander; T Cavallo; M Roy First
Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection.
Transplantation 1997;64(10):1428-32.
1997: AJ Daoud; TJ Schroeder; JM Kano; HR Horn; HB Moran; M Roy First
The US compassionate experience with thymoglobulin for the treatment of resistant acute rejection.
Transplantation proceedings 1997;29(7A):18S-20S.
1997: AJ Daoud; G Bhat; TJ Schroeder
Are surveillance endomyocardial biopsies necessary during OKT3 induction therapy?
Transplantation 1997;64(2):368-70.
1997: John F Valente; S Hariharan; V Ram Peddi; TJ Schroeder; Cora K Ogle; J Wesley Alexander; M Roy First
Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era.
Clinical transplantation 1997;11(3):231-6.
1997: J Regan; K Campbell; L van Smith; P Pouletty; TJ Schroeder; R D Guttmann; Roland Buelow
Characterization of anti-thymoglobulin, anti-Atgam and anti-OKT3 IgG antibodies in human serum with an 11-min ELISA.
Transplant immunology 1997;5(1):49-56.
1997: S Hariharan; V Ram Peddi; Rino Munda; AM Demmy; TJ Schroeder; J Wesley Alexander; M Roy First
Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation.
Transplantation proceedings 1997;29(1-2):652-3.
1997: M el-Ghoroury; S Hariharan; V Ram Peddi; Rino Munda; TJ Schroeder; AM Demmy; J Wesley Alexander; M Roy First
Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients.
Transplantation proceedings 1997;29(1-2):649-51.
1997: TJ Schroeder; R Levy; P Pouletty; M Roy First
A generic cyclosporine development program.
Transplantation proceedings 1997;29(1-2):1235-8.
1997: Lillian W Gaber; Linda Moore; A Osama Gaber; M Roy First; R D Guttmann; P Pouletty; TJ Schroeder; Jean-Paul Soulillou
A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints Conference.
Transplantation proceedings 1997;29(1-2):184-5.
1997: V Ram Peddi; D E Dean; S Hariharan; T Cavallo; TJ Schroeder; M Roy First
Proteinuria following renal transplantation: correlation with histopathology and outcome.
Transplantation proceedings 1997;29(1-2):101-3.
1997: V Ram Peddi; S Hariharan; TJ Schroeder; M Roy First
Impact of ganciclovir prophylaxis on cytomegalovirus infection in recipients of cadaveric renal allografts.
Nephron 1997;76(1):49-55.
1996: TJ Schroeder; M Shah; S Hariharan; M Roy First
Increased resources are required in patients with low cyclosporine bioavailability.
Transplantation proceedings 1996;28(4):2151-5.
1996: Lillian W Gaber; TJ Schroeder; Linda Moore; M H Shakouh-Amiri; A Osama Gaber
The correlation of Banff scoring with reversibility of first and recurrent rejection episodes.
Transplantation 1996;61(12):1711-5.
1996: S Hariharan; Rino Munda; T Cavallo; AM Demmy; TJ Schroeder; J Wesley Alexander; M Roy First
Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity.
Transplantation 1996;61(8):1161-5.
1996: S Hariharan; J Wesley Alexander; TJ Schroeder; M Roy First
Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
Clinical transplantation 1996;10(2):186-90.
1996: M Roy First; TJ Schroeder; A P Monaco; M A Simpson; J J Curtis; V T Armenti
Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations.
Clinical transplantation 1996;10(1 Pt 1):55-9.
1996: V Ram Peddi; S Hariharan; TJ Schroeder; M Roy First
Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients.
Clinical transplantation 1996;10(1 Pt 1):20-3.
1995: M el-Ghoroury; S Hariharan; Rino Munda; AM Demmy; TJ Schroeder; J Wesley Alexander; M Roy First
Comparison between methylprednisolone and OKT3 treatment for the first acute rejection episode in combined kidney and pancreas transplant recipients.
Transplantation proceedings 1995;27(6):3133-4.
1995: V Ram Peddi; S Hariharan; Rino Munda; TJ Schroeder; M Roy First
Impact of ganciclovir prophylaxis on cytomegalovirus infection in cadaveric kidney vs combined kidney and pancreas transplantation.
Transplantation proceedings 1995;27(6):3076-7.
1995: S Hariharan; Rino Munda; AM Demmy; TJ Schroeder; J Wesley Alexander; M Roy First
Conversion from cyclosporine to tacrolimus after pancreas transplantation.
Transplantation proceedings 1995;27(6):2981-2.
1995: TJ Schroeder; S Hariharan; M Roy First
Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations.
Transplantation proceedings 1995;27(1):837-9.
1994: Frederick C Ryckman; TJ Schroeder; S H Pedersen; V S Dittrich; William F Balistreri
Induction therapy with OKT3 in pediatric liver-transplant recipients.
Transplantation science 1994;4 Suppl 1():S20-5.
1994: TJ Schroeder; S Hariharan; M Roy First
Relationship between cyclosporine bioavailability and clinical outcome in renal transplant recipients.
Transplantation proceedings 1994;26(5):2787-90.
1994: S J Rossi; TJ Schroeder; K L Muth; Douglas W Hanto; William F Balistreri; Frederick C Ryckman
Soluble interleukin-2 receptor monitoring during bacterial and viral infections in liver transplant recipients: a comparative evaluation.
Clinical transplantation 1994;8(5):479-84.
1994: R L Madden; TJ Schroeder; J Wesley Alexander; M Roy First
Single dose OKT3: adverse effects, pharmacokinetics, and anti-OKT3 antibody response.
Transplantation science 1994;4(1):111-4.
1994: TJ Schroeder; A T Michael; M Roy First; S Hariharan; G Bhat; Douglas W Hanto; Frederick C Ryckman; William F Balistreri
Variations in serum OKT3 concentration based upon age, sex, transplanted organ, treatment regimen, and anti-OKT3 antibody status.
Therapeutic drug monitoring 1994;16(4):361-7.
1994: David Rush; S F Henry; John R Jeffery; TJ Schroeder; James Gough
Histological findings in early routine biopsies of stable renal allograft recipients.
Transplantation 1994;57(2):208-11.
1994: TJ Schroeder; M Roy First
Monoclonal antibodies in organ transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1994;23(1):138-47.
1993: S Hariharan; TJ Schroeder; Pat Weiskittel; J W Alexander; M Roy First
Prednisone withdrawal in HLA identical and one haplotype-matched live-related donor and cadaver renal transplant recipients.
Kidney international. Supplement 1993;43():S30-5.
1993: S J Rossi; TJ Schroeder; S Hariharan; M Roy First
Prevention and management of the adverse effects associated with immunosuppressive therapy.
Drug safety : an international journal of medical toxicology and drug experience 1993;9(2):104-31.
1993: S Hariharan; TJ Schroeder; M Roy First
Effect of race on renal transplant outcome.
Clinical transplantation 1993;7(3):235-9.
1993: TJ Schroeder; N Sridhar; Amadeo J Pesce; J Wesley Alexander; M Roy First
Clinical correlations of cyclosporine-specific and -nonspecific assays in stable renal transplants, acute rejection, and cyclosporine nephrotoxicity.
Therapeutic drug monitoring 1993;15(3):190-4.
1993: M Roy First; TJ Schroeder; A Michael; S Hariharan; Pat Weiskittel; J Wesley Alexander
Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial.
Transplantation 1993;55(5):1000-4.
1993: K L Muth; TJ Schroeder; Frederick C Ryckman; L A Martin; D Traylor; S H Pedersen; V S Dittrich; William F Balistreri
Soluble interleukin-2 receptor levels in pediatric liver transplant recipients.
Transplantation proceedings 1993;25(2):1783-4.
1993: TJ Schroeder; S Hariharan; M Roy First
Antibody response to OKT3 and methods for monitoring.
Transplantation proceedings 1993;25(2 Suppl 1):77-80.
1993: M Roy First; TJ Schroeder; S Hariharan; Pat Weiskittel
Reduction of the initial febrile response to OKT3 with indomethacin.
Transplantation proceedings 1993;25(2 Suppl 1):52-4.
1993: M Roy First; TJ Schroeder; S Hariharan
OKT3-induced cytokine-release syndrome: renal effects (cytokine nephropathy).
Transplantation proceedings 1993;25(2 Suppl 1):25-6.
1993: M Roy First; TJ Schroeder; A Michael; S Hariharan; Pat Weiskittel; J Wesley Alexander
Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial.
Transplantation proceedings 1993;25(1 Pt 1):591-4.
1993: J Wesley Alexander; C B Davies; M Roy First; B R Cofer; Rino Munda; R L Madden; S Hariharan; TJ Schroeder
Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation.
Transplantation proceedings 1993;25(1 Pt 1):485-7.
1993: TJ Schroeder; M Roy First; C Pouletty; S Hariharan; P Pouletty
Rapid detection of anti-OKT3 antibodies with the Transtat assay.
Transplantation 1993;55(2):297-9.
1992: S J Rossi; TJ Schroeder; W H Vine; H H A-Kader; David A Gremse; Frederick C Ryckman; S H Pedersen; Amadeo J Pesce; William F Balistreri
Monoethylglycinexylide formation in assessing pediatric donor liver function.
Therapeutic drug monitoring 1992;14(6):452-6.
1992: C B Davies; J Wesley Alexander; B R Cofer; M Roy First; TJ Schroeder
Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplant.
Annals of surgery 1992;215(6):618-25; discussion 626.
1992: William F Balistreri; H H A-Kader; K D Setchell; David A Gremse; Frederick C Ryckman; TJ Schroeder
New methods for assessing liver function in infants and children.
Annals of clinical and laboratory science 1992;22(3):162-74.
1992: M Roy First; TJ Schroeder; S Hariharan; J Wesley Alexander; Pat Weiskittel
The effect of indomethacin on the febrile response following OKT3 therapy.
Transplantation 1992;53(1):91-4.
1992: TJ Schroeder; T Helling; RM McKenna; D Rush; J R Jeffrey; B Brewer; L A Martin; D Traylor; R A Fisher; M Roy First
A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
Transplantation 1992;53(1):34-40.
1991: M Roy First; TJ Schroeder
Solid-organ transplantation in the pediatric population.
Clinical transplantation 1991;5(2 part 2):132-6.
1991: RM McKenna; TJ Schroeder
Immunological monitoring in cyclosporine-treated patients.
Clinical biochemistry 1991;24(1):75-80.
1991: M Roy First; TJ Schroeder; J Wesley Alexander; G W Stephens; Pat Weiskittel; S A Myre; Amadeo J Pesce
Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients.
Transplantation 1991;51(2):365-70.
1991: R A Fisher; J I Tchervenkov; TJ Schroeder; J Wesley Alexander; Rino Munda; I Penn; M Carey; M Roy First
Efficacy of induction therapy in cadaveric renal transplantation comparing rabbit antithymocyte serum and Minnesota antilymphoblast globulin.
Transplantation proceedings 1991;23(1 Pt 2):1253-5.
1991: TJ Schroeder; M A Weiss; R D Smith; G W Stephens; M Roy First
The efficacy of OKT3 in vascular rejection.
Transplantation 1991;51(2):312-5.
1991: TJ Schroeder; M A Weiss; R D Smith; G W Stephens; M Carey; M Roy First
The use of OKT3 in the treatment of acute vascular rejection.
Transplantation proceedings 1991;23(1 Pt 2):1043-5.
1991: R W Druckenbrod; C L Mendenhall; S A Myre; E A Stanberry; TJ Schroeder
Effects of controlled liver injury and ethanol pretreatment on monoethylglycine xylidide formation in the rat.
Pharmacology 1991;42(3):169-76.
1991: TJ Schroeder; Amadeo J Pesce; Frederick C Ryckman; T P Tressler; M E Brunson; S H Pedersen; J I Tchervenkov; I Penn; J Wesley Alexander; William F Balistreri
Selection criteria for liver transplant donors.
Journal of clinical laboratory analysis 1991;5(4):275-7.
1990: David A Gremse; H H A-Kader; TJ Schroeder; William F Balistreri
Assessment of lidocaine metabolite formation as a quantitative liver function test in children.
Hepatology (Baltimore, Md.) 1990;12(3 Pt 1):565-9.
1990: N Sridhar; TJ Schroeder; Amadeo J Pesce; M Roy First
Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
Transplantation proceedings 1990;22(3):1257-9.
1990: Amadeo J Pesce; TJ Schroeder; M Roy First
An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.
Transplantation proceedings 1990;22(3):1171-4.
1990: TJ Schroeder; Rino Munda; S H Pedersen; P E Hurtubise; J Wesley Alexander; M Roy First
Failure of orthoclone OKT3 retreatment in a pancreas transplant recipient with antimurine antibodies.
Journal of clinical laboratory analysis 1990;4(2):99-101.
1990: TJ Schroeder; M Roy First; M E Mansour; P E Hurtubise; S Hariharan; Frederick C Ryckman; Rino Munda; David B Melvin; I Penn; W F Ballistreri
Antimurine antibody formation following OKT3 therapy.
Transplantation 1990;49(1):48-51.
1989: M Roy First; TJ Schroeder; M A Carey; D S Chavinson
Effect of race on transplant outcome and response to OKT3 monoclonal antibody therapy.
Transplantation proceedings 1989;21(6):3949-52.
1989: M Roy First; TJ Schroeder; Pat Weiskittel; S A Myre; J Wesley Alexander; Amadeo J Pesce
Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients.
Lancet 1989;2(8673):1198-201.
1989: TJ Schroeder; M Roy First; M E Mansour; J Wesley Alexander; I Penn
Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1989;14(5 Suppl 2):14-8.
1989: T L Wandstrat; TJ Schroeder; S A Myre
Cyclosporine pharmacokinetics in pediatric transplant recipients.
Therapeutic drug monitoring 1989;11(5):493-6.
1989: TJ Schroeder; M Roy First; P E Hurtubise; D J Marmer; D M Martin; M E Mansour; David B Melvin
Immunologic monitoring with Orthoclone OKT3 therapy.
The Journal of heart transplantation 1989;8(5):371-80.
1989: TJ Schroeder; David A Gremse; M E Mansour; A W Theuerling; M E Brunson; Frederick C Ryckman; F J Suchy; I Penn; J Wesley Alexander; Amadeo J Pesce
Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients.
Transplantation proceedings 1989;21(1 Pt 2):2299-301.
1989: M Roy First; TJ Schroeder; P E Hurtubise; M E Mansour; I Penn; Rino Munda; William F Balistreri; J Wesley Alexander; David B Melvin; J P Fidler
Immune monitoring during retreatment with OKT3.
Transplantation proceedings 1989;21(1 Pt 2):1753-4.
1989: S Hariharan; M Roy First; Rino Munda; I Penn; TJ Schroeder; J Fidler; Pat Weiskittel; J Wesley Alexander
Prednisone withdrawal in HLA-identical living related donor transplant recipients.
Transplantation proceedings 1989;21(1 Pt 2):1617-9.
1989: M Roy First; R D Smith; M A Weiss; TJ Schroeder; K S Kant; Rino Munda; G W Stephens; I Penn; J Wesley Alexander
Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation.
Transplantation proceedings 1989;21(1 Pt 2):1567-70.
1989: S A Myre; TJ Schroeder; David B Melvin; Amadeo J Pesce; J A Collins; G W Stephens; M Roy First
Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
Transplantation proceedings 1989;21(1 Pt 3):2484-6.
1989: TJ Schroeder; M E Brunson; Amadeo J Pesce; L L Hindenlang; P A Mauser; D I Ruckrigl; M L Weibel; G Wadih; M Roy First
A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
Transplantation 1989;47(2):262-6.
1989: TJ Schroeder; Amadeo J Pesce; L L Hindenlang; P A Mauser; D L Ruckrigl; M L Weibel; G Wadih; M Roy First
An evaluation of the cyclosporine and metabolites whole blood TDx assay.
Therapeutic drug monitoring 1989;11(4):480-2.
1989: TJ Schroeder; S A Myre; David B Melvin; J Van der Bel-Kahn; G W Stephens; J A Collins; Randall K Wolf; L L Brown; Amadeo J Pesce; M Roy First
Efficacy and safety of constant-rate intravenous cyclosporine infusion immediately after heart transplantation.
The Journal of heart transplantation 1989;8(1):5-10.
1989: J I Tchervenkov; M D Epstein; J Wesley Alexander; TJ Schroeder
The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival.
Transplantation 1989;47(1):177-81.
1989: M Roy First; TJ Schroeder; P E Hurtubise; M E Mansour; I Penn; Rino Munda; William F Balistreri; J Wesley Alexander; David B Melvin; J P Fidler
Successful retreatment of allograft rejection with OKT3.
Transplantation 1989;47(1):88-91.
1988: C W Clardy; TJ Schroeder; S A Myre; N K Wadhwa; Amadeo J Pesce; M Roy First; P T McEnery; William F Balistreri; R E Harris; David B Melvin
Clinical variability of cyclosporine pharmacokinetics in adult and pediatric patients after renal, cardiac, hepatic, and bone-marrow transplants.
Clinical chemistry 1988;34(10):2012-5.
1988: S A Myre; TJ Schroeder; David B Melvin; C W Clardy; Amadeo J Pesce; N K Wadhwa; J A Collins; Randall K Wolf; L L Brown; G W Stephens
Use of cyclosporine by constant-rate intravenous infusion immediately after heart transplantation.
Transplantation proceedings 1988;20(3 Suppl 3):316-22.
1988: Rino Munda; TJ Schroeder; S A Pedersen; C W Clardy; N K Wadhwa; S A Myre; G W Stephens; Amadeo J Pesce; J Wesley Alexander; M Roy First
Cyclosporine pharmacokinetics in pancreas transplant recipients.
Transplantation proceedings 1988;20(2 Suppl 2):487-90.
1988: TJ Schroeder; Amadeo J Pesce; F M Hassan; J R Wermeling; A Warner; K T Schlueter; M Roy First
Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay, and high-performance liquid chromatography methods for the assay of serum cyclosporine.
Transplantation proceedings 1988;20(2 Suppl 2):345-7.
1987: N K Wadhwa; TJ Schroeder; Amadeo J Pesce; S A Myre; C W Clardy; M Roy First
Cyclosporine drug interactions: a review.
Therapeutic drug monitoring 1987;9(4):399-406.
1987: TJ Schroeder; David B Melvin; C W Clardy; N K Wadhwa; S A Myre; J M Reising; Randall K Wolf; J A Collins; Amadeo J Pesce; M Roy First
Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients.
The Journal of heart transplantation 1987;6(2):84-9.
1987: N K Wadhwa; TJ Schroeder; E O'Flaherty; Amadeo J Pesce; S A Myre; M Roy First
The effect of oral metoclopramide on the absorption of cyclosporine.
Transplantation proceedings 1987;19(1 Pt 2):1730-3.
1987: N K Wadhwa; TJ Schroeder; E O'Flaherty; Amadeo J Pesce; S A Myre; M Roy First
The effect of oral metoclopramide on the absorption of cyclosporine.
Transplantation 1987;43(2):211-3.
1987: N K Wadhwa; TJ Schroeder; E O'Flaherty; Amadeo J Pesce; S A Myre; Rino Munda; M Roy First
Interaction between erythromycin and cyclosporine in a kidney and pancreas allograft recipient.
Therapeutic drug monitoring 1987;9(1):123-5.